Differential effect of clofibrate on hepatic drug oxidation and cholesterol 7alpha-hydroxylation.
D000818:Animals; D002784:Cholesterol / Q000378:metabolism*; D002790:Cholesterol 7-alpha-Hydroxylase / Q000378:metabolism; D002792:Cholestyramine Resin / Q000494:pharmacology; D002994:Clofibrate / Q000494:pharmacology*; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D006899:Mixed Function Oxygenases / Q000378:metabolism; D010084:Oxidation-Reduction; D051381:Rats
D002792:Cholestyramine Resin; D002784:Cholesterol; D006899:Mixed Function Oxygenases; D002790:Cholesterol 7-alpha-Hydroxylase; D002994:Clofibrate